“…Antibodies used were against Pax6, Pax7, Pax2, Evx1, Nkx2.2, Isl1, Lim1/Lim2, Lmx1b, N-cadherin, Nkx6.1 and En1 (DSHB); mouse anti--catenin (Sigma); rabbit anti-Dbx1 (Pierani et al, 1999); anti-Chx10 (S. Morton, Columbia University, NY, USA); rabbit anti-Pax6 (Covance); rabbit anti-Olig2 polyclonal and rabbit anti-RFP polyclonal (Chemicon); rabbit anti-phospho-histone H3 polyclonal (Upstate); rabbit anti-GFP polyclonal (BD Bioscience); anti-Crb2 (P. Rashbass, University of Sheffield, UK); rabbit anti-pYap1 polyclonal (Cell Signaling Technology); and Alexa405-, Alexa488-and Alexa555-conjugated secondary antibodies were obtained from Molecular Probes (Invitrogen). Whole-mount in situ hybridisation was performed as previously described (Ohyama et al, 2005;Das et al, 2006) using digoxigenin (DIG)-labelled (Roche) RNA probes. DIG-labelled antisense riboprobes were generated from chicken EST plasmids ChEST187n19 (FatJ); ChEST427d5 (Yap1) and ChEST580f24 (Tead4) [by linearization with NotI and transcription with T3 RNA polymerase (Promega)].…”